Literature DB >> 10080466

The economic consequences of available diagnostic and prognostic strategies for the evaluation of stable angina patients: an observational assessment of the value of precatheterization ischemia. Economics of Noninvasive Diagnosis (END) Multicenter Study Group.

L J Shaw1, R Hachamovitch, D S Berman, T H Marwick, M S Lauer, G V Heller, A E Iskandrian, K L Kesler, M I Travin, H C Lewin, R C Hendel, S Borges-Neto, D D Miller.   

Abstract

OBJECTIVES: The study aim was to determine observational differences in costs of care by the coronary disease diagnostic test modality.
BACKGROUND: A number of diagnostic strategies are available with few data to compare the cost implications of the initial test choice.
METHODS: We prospectively enrolled 11,372 consecutive stable angina patients who were referred for stress myocardial perfusion tomography or cardiac catheterization. Stress imaging patients were matched by their pretest clinical risk of coronary disease to a series of patients referred to cardiac catheterization. Composite 3-year costs of care were compared for two patients management strategies: 1) direct cardiac catheterization (aggressive) and 2) initial stress myocardial perfusion tomography and selective catheterization of high risk patients (conservative). Analysis of variance techniques were used to compare costs, adjusting for treatment propensity and pretest risk.
RESULTS: Observational comparisons of aggressive as compared with conservative testing strategies reveal that costs of care were higher for direct cardiac catheterization in all clinical risk subsets (range: $2,878 to $4,579), as compared with stress myocardial perfusion imaging plus selective catheterization (range: $2,387 to $3,010, p < 0.0001). Coronary revascularization rates were higher for low, intermediate and high risk direct catheterization patients as compared with the initial stress perfusion imaging cohort (13% to 50%, p < 0.0001); cardiac death or myocardial infarction rates were similar (p > 0.20).
CONCLUSIONS: Observational assessments reveal that stable chest pain patients who undergo a more aggressive diagnostic strategy have higher diagnostic costs and greater rates of intervention and follow-up costs. Cost differences may reflect a diminished necessity for resource consumption for patients with normal test results.

Entities:  

Mesh:

Year:  1999        PMID: 10080466     DOI: 10.1016/s0735-1097(98)00606-8

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  100 in total

1.  Optimal clinical strategies: considering costs and outcomes.

Authors:  H M Krumholz
Journal:  J Nucl Cardiol       Date:  1999 Nov-Dec       Impact factor: 5.952

Review 2.  Clinical and economic outcomes assessment with myocardial contrast echocardiography.

Authors:  L J Shaw; M J Monaghan; P Nihoyannopolous
Journal:  Heart       Date:  1999-11       Impact factor: 5.994

Review 3.  Assessing diagnostic performance in nuclear cardiology.

Authors:  Dan Koller
Journal:  J Nucl Cardiol       Date:  2002 Jan-Feb       Impact factor: 5.952

4.  Cardiac risk defined by stress myocardial perfusion imaging: Impact on physician decision making and cost savings.

Authors:  Kenneth A Brown
Journal:  J Nucl Cardiol       Date:  2002 Jan-Feb       Impact factor: 5.952

5.  Beyond the cholesterol profile: monitoring therapeutic effectiveness of statin therapy.

Authors:  R G Schwartz
Journal:  J Nucl Cardiol       Date:  2001 Jul-Aug       Impact factor: 5.952

6.  Volatility in the diagnostic markets: is there a "new economy" of testing?

Authors:  D D Miller; L J Shaw
Journal:  J Nucl Cardiol       Date:  2001 Sep-Oct       Impact factor: 5.952

7.  A pilot study on diagnosis of coronary artery disease using computed tomography first-pass myocardial perfusion imaging at rest.

Authors:  Qi Wang; Jing Qin; Lu-yue Gai; Yun-dai Chen; Wei Dong; Zhi-wei Guan; Zhi-guo Wang; Zhi-jun Sun; Jia-he Tian
Journal:  J Zhejiang Univ Sci B       Date:  2011-06       Impact factor: 3.066

8.  Do we need more nuclear cardiologists in Europe?

Authors:  S Richard Underwood
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-01-28       Impact factor: 9.236

Review 9.  Non-invasive functional assessment using computed tomography: when will they be ready for clinical use?

Authors:  Yeonyee E Yoon; Bon-Kwon Koo
Journal:  Cardiovasc Diagn Ther       Date:  2012-06

Review 10.  Role of myocardial perfusion imaging for risk stratification in suspected or known coronary artery disease.

Authors:  N K Sabharwal; A Lahiri
Journal:  Heart       Date:  2003-11       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.